FFA
FULC icon

Farther Finance Advisors’s Fulcrum Therapeutics FULC Stock Holding History

Farther Finance Advisors’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.46K Sell
2,285
-177
-7% -$664 ﹤0.01% 4724
2026
Q2 		$9.16K Buy
2,462
+72
+3% +$438 ﹤0.01% 4479
2026
Q1 		$17.9K Buy
2,390
+200
+9% +$1.85K ﹤0.01% 3737
2025
Q4 		$24.8K Sell
2,190
-4,922
-69% -$50.1K ﹤0.01% 3293
2025
Q3 		$65.4K Buy
7,112
+3,697
+108% +$26.7K ﹤0.01% 2293
2025
Q2 		$23.5K Buy
3,415
+1,394
+69% +$7.46K ﹤0.01% 2576
2025
Q1 		$5.58K Buy
+2,021
New +$7.42K ﹤0.01% 3005

Other funds holding FULC

CP
Castleview Partners Dallas, Texas $228M AUM 13.32% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors's FULC Position: Q3 2026 in Review

Farther Finance Advisors reduced its Fulcrum Therapeutics (FULC) stake by 7.2% in Q3 2026, selling an estimated $664 and leaving 2,285 shares worth $8.46K. The position accounts for ﹤0.01% of the portfolio, ranked #4724.

Farther Finance Advisors first reported a position in FULC in Q1 2025 and has held it in 7 quarters since. The position peaked at $65.4K in Q3 2025. 4 funds tracked by Wall St. Rank hold FULC as of Q3 2026.

  • Farther Finance Advisors held 2,285 shares of Fulcrum Therapeutics worth $8.46K as of Q3 2026.
  • Farther Finance Advisors sold 177 Fulcrum Therapeutics shares in Q3 2026, an estimated $664.
  • Fulcrum Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4724 holding.
  • Farther Finance Advisors first reported a position in Fulcrum Therapeutics in Q1 2025 and has held it in 7 quarters since.
  • Farther Finance Advisors's Fulcrum Therapeutics position peaked at $65.4K in Q3 2025.
  • 4 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.